Amgen Perfectly Positioned To Deal With Prolia Complete Response Letter; Quick Turn-Around Expected

FDA handed Amgen a complete response letter for Prolia, but the company has an armamentarium for handling the agency's requests.

More from Archive

More from Pink Sheet